Mazen Animal Health - Oral Vaccines
Slogan: Game-changing animal disease prevention with orally-delivered, RT stable, cost effective vaccines for a healthier planet
Description: Mazen Animal Health, Inc. is a biotechnology company founded in 2015 that is revolutionizing animal vaccines by transforming corn seed into the future of animal vaccines. The company has successfully produced proof of efficacy data for two vaccine candidates, each addressing a significant unmet need. Mazen's innovative approach involves creating vaccines to be delivered orally with animal feed, providing solutions to the challenges associated with injectable vaccines, including increased production system ROI, a safer method of vaccine administration, optimized vaccine efficacy, and global reach due to ambient temperature stability and ease of delivery. The platform technology expresses antigens in corn seed and improves the standard vaccine manufacturing cost structure, offering cost-effective disease prevention that benefits the environment with decreased losses and increased productivity of protein to feed our planet.
Industries: Biotechnology, Health Care, Pharmaceutical
Headquarter: United States
Last Investment: $11.27M Series A investment at 05 May 2022
Last Investment Investors: AgFunder, Fall Line Capital, SLO Seed Ventures, Next Level Ventures, Addison Biological Laboratory, Kent, ISAV, Ag Startup Engine, 1330 Investments, Summit Agricultural Group
For more information, visit www.mazenanimalhealth.com, or follow us on Twitter at twitter.com/mazenanimal.
No recent news or press coverage available for Mazen Animal Health - Oral Vaccines.